AlloVir, Inc (NASDAQ:ALVR) Receives Consensus Recommendation of Reduce from Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
SVB Leerink downgraded shares of AlloVir (NASDAQ:ALVR – Free Report) from an outperform rating to a market perform rating in a report published on Friday, MarketBeat reports. ALVR has been the topic of several other research reports. Piper Sandler downgraded shares of AlloVir from an overweight rating to a neutral rating in a research note […]
Equities researchers at Bank of America began coverage on shares of AlloVir (NASDAQ:ALVR – Get Free Report) in a note issued to investors on Friday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. Several other brokerages have also weighed in on ALVR. Morgan Stanley restated an “overweight” rating and issued a $20.00 […]
GMT Capital Corp Raises Stock Position in AlloVir, Inc (NASDAQ:ALVR) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
AlloVir, Inc. (NASDAQ:ALVR – Free Report) – Equities researchers at SVB Leerink lifted their Q2 2023 EPS estimates for shares of AlloVir in a research note issued on Monday, June 26th. SVB Leerink analyst M. Foroohar now forecasts that the company will earn ($0.37) per share for the quarter, up from their prior forecast of […]